Skip to main content

Table 2 Differences in cannabis use characteristics between the SCRA + cannabis group and the cannabis-only group participants

From: The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients

Cannabis use characteristic SCRA + cannabis (n = 82) Cannabis-only (n = 72) p-value
Used in past 3 months, n (%) 74 (90%) 68 (94%) 0.33
Used in past month, n (%) 63 (88%) 67 (91%) 0.32
Number of days used in past month, m(sd) 16.4 (11.2) 21.0 (10.3) 0.01
Average amount used per day (grammes), m(sd) 1.7 (1.8) 2.9 (4.5) 0.03
Age of initiation (years), m(sd) 14.2 (3.0) 14.7 (2.9) 0.33
No. of ICD-10 symptoms, mdn(IQR) 5 (2) 6 (1)  < 0.01
Route of administration:
 Water pipe, n (%) 71 (99%) 82 (100%) 0.28
 Joints, n (%) 77 (94%) 65 (90%) 0.14
 Dry pipe, n (%) 73 (89%) 53 (74%) 0.02
 Vaporiser, n (%) 27 (33%) 17 (24%) 0.27
 Ingested, n (%) 72 (88%) 46 (64%)  < 0.01